Sarah Bell

Q: What Schools Are Affiliated With Sarah Bell

Sarah Bell is affiliated with the following schools: University of California, Berkeley, University College London, University of Melbourne, Stanford University, Murdoch University, Monash University

Sarah Bell's AcademicInfluence.com Rankings

Sarah Bell

Earth Sciences

#2594

World Rank

#3498

Historical Rank

Environmental Science

#324

World Rank

#327

Historical Rank

earth-sciences Degrees

Sarah Bell

Engineering

#4817

World Rank

#6038

Historical Rank

Environmental Engineering

#92

World Rank

#94

Historical Rank

Applied Physics

#3141

World Rank

#3214

Historical Rank

engineering Degrees

Download Badge

Earth Sciences
Engineering

Sarah Bell's Degrees

PhD Environmental Engineering Stanford University
Masters Environmental Science University of California, Berkeley

Why Is Sarah Bell Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sarah Jayne Bell is the City of Melbourne Chair in Urban Resilience and Innovation at the University of Melbourne, Australia, and Honorary Professor of Environmental Engineering at The Bartlett School in University College London . She works on urban water systems. She was the Director of the UCL Engineering Exchange during her 16 years as a Professor of Environmental Engineering at UCL.

(See a Problem?)

Sarah Bell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Managing the health effects of climate change Lancet and University College London Institute for Global Health Commission (2009) (1513)
Managing the health effects of climate change (2009) (779)
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. (2013) (645)
Crohn's disease management after intestinal resection: a randomised trial (2015) (436)
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. (2010) (355)
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific (2014) (297)
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. (2016) (252)
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. (2015) (241)
High incidence of inflammatory bowel disease in Australia: A prospective population‐based Australian incidence study (2010) (186)
Assessment of building-integrated green technologies: A review and case study on applications of Multi-Criteria Decision Making (MCDM) method (2016) (169)
Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging (2003) (165)
HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants (2014) (164)
Governing the UN sustainable development goals: interactions, infrastructures, and institutions. (2015) (163)
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. (2018) (133)
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific (2018) (125)
Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. (2015) (107)
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis (2015) (102)
Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. (2016) (96)
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. (2014) (95)
Antibodies to tumour necrosis factor α as treatment for Crohn's disease (2000) (82)
Urban water reuse: A triple bottom line assessment framework and review (2016) (82)
eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis (2014) (77)
Prospective population‐based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity (2015) (77)
Influence of food and lifestyle on the risk of developing inflammatory bowel disease (2016) (65)
Liver stiffness plus platelet count can be used to exclude high‐risk oesophageal varices (2016) (65)
Faecal diversion in the management of perianal Crohn’s disease (2011) (62)
Renegotiating urban water (2015) (58)
A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease (2016) (57)
Water and the city: risk, resilience and planning for a sustainable future (2011) (54)
Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg‐negative but not HBeAg‐positive chronic hepatitis B (2010) (50)
Novel population‐based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed (2016) (50)
Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. (2000) (49)
A systems framework for national assessment of climate risks to infrastructure (2018) (47)
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease (2017) (47)
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon‐α (2013) (46)
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors (2007) (45)
Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis. (2015) (43)
Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia (2016) (41)
Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease (2013) (38)
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study (2017) (37)
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study (2018) (37)
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort. (2015) (36)
Managing the health effects of climate (2009) (36)
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne (2012) (34)
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study (2015) (33)
Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. (2005) (33)
Public acceptability of indirect potable water reuse in the south-east of England (2014) (32)
Effect of intestinal resection on quality of life in Crohn's disease. (2015) (29)
Agriculture for Health and Profit in Western Australia: The Western Oil Mallee Project (2001) (28)
Governing Sustainable Development Goals: interactions, infrastructures, and institutions (2015) (28)
Altered Immune System Glycosylation Causes Colitis in &agr;1,2-Fucosyltransferase Transgenic Mice (2004) (28)
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C. (2018) (27)
Allergic reactions to rubber in patients with myelodysplasia. (1990) (26)
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method (2017) (26)
925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. (2013) (24)
Engineers, Society, and Sustainability (2011) (24)
Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection (2017) (23)
Public engagement with water conservation in London (2011) (22)
Demolition or Refurbishment of Social Housing? A review of the evidence (2014) (22)
OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study (2014) (22)
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study (2017) (22)
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure (2020) (21)
1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study (2012) (21)
Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience (2017) (20)
Retrofitting urban drainage infrastructure: green or grey? (2018) (20)
Urban Water Systems In Transition (2012) (20)
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease (2018) (20)
Serologic antibodies in relation to outcome in postoperative Crohn's disease (2017) (19)
GEO-6 assessment for the pan-European region (2016) (19)
Efficacy and tolerability of pegylated interferon‐α‐2a in chronic hepatitis B: A multicenter clinical experience (2012) (19)
Thiopurine metabolite testing in inflammatory bowel disease (2016) (19)
Emerging Community Food Production And Pathways For Urban Landscape Transitions (2012) (19)
Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography. (2020) (18)
G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective. (2011) (18)
The driest continent and the greediest water company: newspaper reporting of drought in Sydney and London (2009) (17)
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. (2019) (16)
The socio-technology of indirect potable water reuse (2008) (16)
Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study (2017) (16)
‘Teach-back’ is a simple communication tool that improves disease knowledge in people with chronic hepatitis B – a pilot randomized controlled study (2019) (15)
Imagining the Future City : London 2062 (2013) (15)
Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study (2012) (15)
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival (2018) (14)
Network priorities for social sustainability research and education: Memorandum of the Integrated Network on Social Sustainability Research Group (2016) (14)
Constructing Sustainable Rural Landscapes: Oil Mallees and the Western Australian Wheatbelt (2005) (14)
Adalimumab levels in an infant. (2013) (12)
Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B (2013) (12)
Letter: vedolizumab drug concentrations in neonates following intrauterine exposure (2018) (12)
Aceruloplasminaemia: a disorder of diabetes and neurodegeneration (2017) (12)
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford (2020) (12)
Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures (2020) (11)
Severity of liver disease in hepatitis C infection contracted through injecting drug use. (1999) (11)
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates (2021) (10)
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial. (2021) (10)
Updates in the management of inflammatory bowel disease during pregnancy (2019) (10)
“B in IT” - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool (2018) (10)
Cost-effectiveness of Crohn's disease post-operative care. (2016) (10)
Urban Water Sustainability: Constructing Infrastructure for Cities and Nature (2017) (10)
78 Incidence and Phenotype of Inflammatory Bowel Disease From 13 Countries in Asia-Pacific: Results From the Asia-Pacific Crohn's and Colitis Epidemiologic Study 2011-2013 (2016) (9)
Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study (2016) (9)
Glass half empty? Urban water poverty halfway through the Decade of Water for Life (2011) (9)
Tu1164 Environmental Risk Factors in Inflammatory Bowel Disease in Asia-Pacific: A Population-Based Case-Control Study (2014) (9)
Development of LCA Calculator to support community infrastructure co-design (2018) (8)
Concerned scientists, pragmatic politics and Australia's green drought (2006) (8)
Urban Water Trajectories (2017) (7)
Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age. (2020) (7)
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero (2021) (7)
Epidemiology of hepatitis B‐associated hepatocellular carcinoma in Victoria (2013) (7)
Severe recurrent Crohn’s disease of the ileocolonic anastomosis disappearing completely with antibacterial therapy (2005) (6)
Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study (2012) (6)
Neo-hydraulic water management: an international comparison of idle desalination plants (2019) (6)
Frameworks for urban water sustainability (2020) (6)
Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease (2020) (6)
Hepatitis C--an update. (2013) (5)
Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia (2019) (5)
Working with Infrastructural Communities: A Material Participation Approach to Urban Retrofit (2020) (5)
312 The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors (2016) (4)
P660 Stability of serum concentrations of infliximab and adalimumab across pregnancy in IBD (2019) (4)
Analysing the Relationship between Urban Livelihoods and Water Infrastructure in Three Settlements in Cusco, Peru (2012) (4)
The socio-technology of alternative water systems (2015) (4)
Su1318 Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the POCER Study (2014) (4)
Sa1006 Factors Predicting Progression of Hepatitis C Associated Fibrosis: A Decade Long Follow-up (2012) (4)
Crossing Disciplines to Address Urban Sustainability (2012) (4)
Researching sustainability: material semiotics and the Oil Mallee Project (2003) (4)
540 Adalimumab and Infliximab Levels in Neonates (ERA Study) (2015) (4)
P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: E (2012) (4)
Retrofitting sustainable integrated water management (2014) (4)
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. (2021) (4)
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease. (2018) (4)
Adalimumab and infliximab levels in neonates (ERA study) (2015) (4)
Bowel Dysfunction : Assessment and Management in the Neurological Patient (4)
Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing (2012) (4)
Community participation in decentralised rainwater systems: A Mexican case study (2014) (4)
Ageism in renal replacement therapy. (2003) (3)
P683 Infliximab, adalimumab and vedolizumab levels are not altered by pregnancy progression in IBD patients and neonatal vedolizumab levels are lower than in mothers: Results from the PICCOLO study (2020) (3)
Cyclophosphamide-associated enteritis: A rare association with severe enteritis (2016) (3)
6 thiopurine induced pancreatitis in inflammatory bowel disease : clinical features and genetic determinants (2014) (3)
Hereditary iron overload in the Asia Pacific: first identification of ferroportin disease in a Vietnamese family (2010) (3)
The management of hepatitis B (2009) (3)
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation (2020) (3)
Post-Operative Crohn's Disease Recurrence: Impact of Endoscopic Monitoring and Treatment Step-up on Outcome (2011) (3)
1004 RADIOFREQUENCY ABLATION VERSUS SURGICAL RESECTION FOR THE TREATMENT OF EARLY STAGE HEPATOCELLULAR CARCINOMA (HCC) - A LARGE MULTICENTRE STUDY (2012) (3)
Addressing pregnancy‐related concerns in women with inflammatory bowel disease: Insights from the patient's perspective (2020) (3)
Hepatitis B Virus (2009) (3)
Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study) (2014) (3)
Briefing: Creating sustainable urban water systems (2013) (3)
Retrofitting Sustainable Integrated Water Management at Household, Building and Urban Scales (2014) (3)
Cities, Communities and Homes: Is the Urban Future Livable? (2017) (3)
Shaping Urban Infrastructures: Intermediaries and the Governance of Socio-technical Networks (2012) (2)
Intervening in the City: Co-designing Neighbourhood Infrastructure with Residents of a London Housing Estate (2018) (2)
Therapies for Chronic Hepatitis B: Review of Indications, Outcomes and New Tools for Tailoring Treatments to Patients (2014) (2)
998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study (2014) (2)
Su1312 The First Prospective Australian Population-Based Study of Newly Diagnosed IBD Identifies Frequent Use of Immunomodulators, Low Surgery Rates and High Cost From Medications and Investigations (2015) (2)
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study (2022) (2)
Prospective Evaluation of Early Post-Operative Crohn's Recurrence in the Presence of Optimal Drug Therapy – Is Endoscopic Evaluation Worthwhile? (2011) (2)
597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study (2015) (2)
Comparison of adalimumab serum drug levels when delivered by pen versus syringe in patients with inflammatory bowel disease. An international, multicentre cohort analysis. (2019) (2)
DOP064 Faecal calprotectin is superior to faecal lactoferrin and S100A12 (2014) (2)
The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy. (2021) (2)
Integrating social and technical factors in decision support for non-potable water reuse networks (2013) (2)
Rainwater harvesting for a sustainable and resilient London (2009) (2)
Longitudinal observation of viral load changes in untreated HBeAg negative chronic hepatitis B. (2013) (2)
P260 Point of Care Ultrasound (POCUS) when performed by gastroenterologists with 200 supervised scans is accurate and clinically useful for patients with Crohn’s disease (2018) (1)
Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study (2021) (1)
Community Approach Targeting Cirrhosis and Hepatocellular Carcinoma – Catch (2016) (1)
Presenting Futures: London 2062 (2017) (1)
Accuracy of point‐of‐care intestinal ultrasound for Crohn's disease (2020) (1)
Crohn's Disease Phenotype at Diagnosis is More Severe in the East (China) Than the West (Australia) and is Managed Differently. (2011) (1)
Reviews: Transit Oriented Development: Making it Happen, the Handbook of Environment and Society, City Planning for Civil Engineers, Environmental Engineers, and Surveyors, Statistical Detection and Surveillance of Geographic Clusters, Whose Public Space? International Case Studies in Urban Design a (2010) (1)
Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease (2012) (1)
Reconfiguring nexus infrastructure from the bottom up (2016) (1)
459 CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. THE STRIDENT RANDOMISED CONTROLLED TRIAL. (2021) (1)
Mo1821 Medical Therapy, Surgery and Hospitalization Rates During the 2-and 3-Year Follow-Up of the 2011 ECCO-EpiCom Cohort (2016) (1)
P0702 : CC IL28B Genotype is associated with high liver necroinflammation and increased expression of TH1 cytokines (CYK) and chemokines (CHK), but also higher TH2 CYK which may drive low ISG expression (2015) (1)
P520 Gastrointestinal ultrasonography in pregnant patients with IBD is useful in the identification of active intestinal inflammation (2018) (1)
A Composite Index Approach to Assessing Water Scarcity: a Case Study from Mexico (2008) (1)
Survival of patients with ruptured and non‐ruptured hepatocellular carcinoma (2020) (1)
Engineering Comes Home: Co-designing nexus infrastructure from the bottom-up (2017) (1)
DOP086 Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study (2014) (1)
Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series. (2021) (1)
In hepatitis C patients with cirrhosis who achieve SVR with treatment, reduction in transient elastography measures does not translate to reduced risk of hepatocellular carcinoma: A prospective cohort study (2018) (1)
Methodological considerations in studying natural history of HBeAg‐negative and ‐positive chronic hepatitis B: authors' reply (2012) (1)
P377 Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study (2014) (1)
354 PREVALENCE OF SIGNIFICANT FIBROSIS AND CORRELATIONS BETWEEN HISTOLOGICAL INFLAMMATION AND FIBROSIS SCORES AND SERUM HEPATITIS B (HBV) DNA LEVELS IN CHRONIC HEPATITIS B (2009) (1)
Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era (2020) (1)
514 IL28B GENOTYPE IS NOT USEFUL FOR PREDICTING TREATMENT OUTCOME IN ASIAN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGYLATED-INTERFERON-A (PIFN) (2012) (1)
W1114 Methotrexate in Thiopurine Refractory Crohn's Disease - a Retrospective Cohort Study (2009) (1)
Pregnancy and IBD (2019) (1)
Early progression to high‐grade dysplasia in a patient with ulcerative colitis and primary sclerosing cholangitis (2005) (1)
Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network. (2022) (1)
Communicating About Water Security Under a Changing Climate (2019) (1)
DOP041 Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth (2014) (1)
P621 The natural history of inflammatory bowel disease (IBD) in an Australian based community cohort: investigating predictors of severe disease and risk of complications (2013) (1)
Tacit knowledge in water management: a case study of Sponge City (2021) (1)
W1008 Outcome of Chronic Hepatitis C Patients Referred for Pre Therapy Psychiatric Evaluations (2008) (0)
Chapter 5 Water Reuse Trajectories (2019) (0)
Mo1883 - Is There a Difference in Adalimumab Drug Levels According to Pen vs. Syringe use - An International, Multicenter Retrospective Analysis (2018) (0)
Co-designing Infrastructures (2023) (0)
864 ITPA ACTIVITY PREDICTS Hb DECLINE AFTER FOUR WEEKS OF PI TRIPLE THERAPY, REGARDLESS OF PREVIOUS TREATMENT OR NAÏVE STATUS AND FIBROSIS: A MULTICENTER REAL-LIFE EXPERIENCE (2013) (0)
Anti-platelet therapy with clopidogrel or dipyridamole has no significant effect on Dss-induced murine colitis. (2007) (0)
Framing cities and nature (2017) (0)
Payers Have Biologic Alternative for Patients With Moderate to Severe Rheumatoid Arthritis Who Do Not Respond to Other DMARD Therapies. (2006) (0)
Review: The effect of in-utero exposure to maternal inflammatory bowel disease and immunomodulators on infant immune system development and function. (2023) (0)
Water and sustainable cities (2017) (0)
Tu1289 Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels (2015) (0)
Reply (2006) (0)
Population-Based Clinical Cohort Allows Mapping of Hepatocellular Carcinoma Incidence and Risk Factors to Enable Targeted Surveillance (2016) (0)
236 INFLIXIMAB, ADALIMUMAB AND VEDOLIZUMAB LEVELS ARE NOT ALTERED BY PREGNANCY PROGRESSION IN IBD PATIENTS AND NEONATAL VEDOLIZUMAB LEVELS ARE LOWER THAN IN MOTHERS: RESULTS FROM THE PICCOLO STUDY (2020) (0)
P640 A prospective population-based natural history registry of newly diagnosed IBD identifies high rates of severe disease and immunomodulator use after 1 year (2014) (0)
Prevention of hepatitis A and B. (1997) (0)
The Human in the Water-cycle (2010) (0)
LivR Well: a feasibility study for a home-based, multidisciplinary liver optimization program for the first 28 days after an admission for acute-on-chronic liver failure (2022) (0)
Hepatocellular carcinoma surveillance in primary care (2016) (0)
Examining the role of thiopurine metabolite testing in the management of patients with autoimmune hepatitis (2022) (0)
Water Reuse Trajectories (2017) (0)
Demonstration of hypercoagulability in the hfut1 transgenic mouse model of colitis. (2005) (0)
A simple clinical rule based on liver stiffness measurement and platelet count can be used to exclude the presence of clinically significant portal hypertension (2013) (0)
Chemoprevention of colorectal cancer in ulcerative colitis. Authors' reply (2006) (0)
Mo1879 - Vedolizumab(VDZ) Real World Outcomes in Ulcerative Colitis (UC) (2018) (0)
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis (2021) (0)
Hacking London’s Demolition Decisions: A new collaboration to scrutinise the technical justifications for retrofit, refurbishment and demolition (2016) (0)
Sustainable district infrastructure in Cusco, Peru (2007) (0)
The Human in the Water-cycle L'intervention de l'homme dans le cycle de l'eau (2010) (0)
Community Approach Targeting Cirrhosis and Hepatocellular carcinoma (CATCH): community prevalence of advanced fibrosis in viral hepatitis (2017) (0)
Cd39 a nuclcotide triphosphate diphosphorylase worsens Colitis in the Huft1 transgenic mouse. (2005) (0)
Short‐term intraperitoneal catheters: An ambulatory care intervention for refractory ascites secondary to cirrhosis during COVID‐19 (2021) (0)
Water efficiency-people and communities (2015) (0)
Virological Characterization of Chronic Hepatitis B in Australia: High Prevalence of Variants Associated with Disease Progression (2016) (0)
CIVIL & ENVIRONMENTAL ENGINEERING | RESEARCH ARTICLE Estimating a municipal water supply reliability (2015) (0)
GroundsWell: Community-engaged and data-informed systems transformation of Urban Green and Blue Space for population health – a new initiative (2022) (0)
Trigger finger as the first presentation of Dupuytren’s disease (2015) (0)
The basics — how to treat perianal Crohn’s disease (2007) (0)
253 COMPARISON OF SURVIVAL OUTCOMES BETWEEN PATIENTS WITH VIRAL AND NON-VIRAL RELATED HEPATOCELLULAR CARCINOMA: A LARGE MULTI-CENTRE STUDY (2013) (0)
T1173 Beware the Ides of March: Seasonal Variation in Quality of Life (QOL) in Inflammatory Bowel Disease (IBD) (2008) (0)
Timing of live attenuated vaccination in infants exposed to infliximab or adalimumab in utero: A prospective cohort study in 107 children. (2022) (0)
P536 Thiopurine metabolite levels in pregnant IBD patients and infants following intrauterine thiopurine exposure (2019) (0)
Acute-on-chronic liver failure: Controversies and consensus (2023) (0)
Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD) (2018) (0)
The effects of thrombomodulin on experimental colitis (2006) (0)
1154 Influence of ethnicity and HBSAG status on the selection of lamivudine resistance (2003) (0)
P328 Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD) (2018) (0)
Ulcerative Colitis at Diagnosis is More Extensive Anatomically in the East (China) Than the West (Australia) and is Managed Differently. (2011) (0)
P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC) (2018) (0)
Preconception, antenatal and postpartum management of inflammatory bowel disease. (2022) (0)
The association of IL28B genotype with peginterferon-alpha/ribavirin ( PR) treatment outcome and liver interferon-stimulated gene (ISG) expression is determined by HCV genotype (2012) (0)
What causes post-operative Crohn's disease recurrence? Evaluation of gut microbiota, anti-TNF non-response and smoking (2015) (0)
Protective effects of thrombomodulin in DSS-induced murine colitis. (2007) (0)
Salvage Therapy with Sofosbuvir, Elbasvir, Grazoprevir and Ribavirin for Daa Non-Responders - High Efficacy in GT3 and GT1/4 HCV Infection (2018) (0)
Clinical risk stratification accurately predicts development of endoscopic recurrence after Crohn (2012) (0)
Impact of COVID‐19 telehealth on outpatient test completion (2021) (0)
Adalimumab and Infliximab clearance in neonates (Era Study) (2015) (0)
Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis (2018) (0)
P293 eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis (2014) (0)
219 Incidence and Phenotype At Diagnosis of Inflammatory Bowel Disease Across 9 Countries in Asia-Pacific (2013) (0)
Contrast Radiology in the Management of Small Bowel Obstruction (1998) (0)
Pregnancy outcome and counselling of anti-TNF-α treated IBD women. (2014) (0)
ITPA genotype predicts the development of on-treatment anaemia after 4 weeks of protease inhibitor therapy irrespective of fibrosis stage and past treatment experience status: A multi-centre real-life experience (2013) (0)
P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis (2018) (0)
EP1306: PREGNANCY IN CROHN'S AND COLITIS - OBSERVATONS, LEVELS AND OUTCOMES EXTENSION (PICCOLO-X) STUDY: BIOLOGIC THERAPY REDUCES FAECAL CALPROTECTIN AND THE NEED FOR CORTICOSTEROIDS IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE (2022) (0)
Predictive Power of Clinical Stigmata in Detecting Advanced Liver Disease (2016) (0)
P312 Thiopurine metabolite testing in inflammatory bowel disease (2014) (0)
P511 Radiological outcomes in perianal fistulising Crohn’s disease (2019) (0)
Oral ulcers: thinking beyond inflammatory bowel disease (2022) (0)
High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. (2019) (0)
Su1252 The Natural History of Inflammatory Bowel Disease (IBD) in an Australian Based Community Cohort: Investigating Predictors of Severe Disease and Risk of Complications (2013) (0)
Safety of in utero exposure to maternal IBD pharmacotherapies (2022) (0)
The effects of tissue factor pathway inhibitor on experimental colitis (2006) (0)
Acute Severe Ulcerative Colitis Causing Toxic Megacolon in an Australian Expatriate (2018) (0)
42 – Thiopurine Metabolite Levels in Pregnant IBD Patients and Infants Following Intrauterine Exposure (2019) (0)
P627 Audit of the assessment, prevalence and treatment of osteoporosis in a single-centre cohort of patients with inflammatory bowel disease managed with tumour necrosis factor inhibitor treatment (2018) (0)
P734 The sex ratio of inflammatory bowel disease varies according to age at onset: results from a worldwide survey. (2017) (0)
Mo1836 A Survey of Hepatitis B Screening Prior to Rituximab-Containing Therapy for Lymphoproliferative Disorders (2012) (0)
Mo1009 Elastography Plus Platelet Count Rather Than Endoscopy to Screen for Clinically Significant Esophageal Varices (2014) (0)
High incidence of hepatocellular carcinoma in melbourne: Results from a population-based epidemiological study (2013) (0)
Altered cell surface glycosylation leads to defective T-cell selection and Th1 type, microflora dependent colitis in α1–2 fucosyltransferase (hFUT1) transgenic mice (2003) (0)
Sa1143 Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications (2015) (0)
Clinical outcomes of patients with two small hepatocellular carcinomas (2021) (0)
Inflammatory bowel disease incidence, prevalence and twelve-month initial disease course in Tasmania, Australia: IBD epidemiology in Tasmania (2018) (0)
G80S-linked ferroportin disease: classical ferroportin disease in an Australian family of Asian descent and reclassification of the mutant as iron transport defective (2010) (0)
Agriculture for Health and Profit (2001) (0)
The sick and septic mother (2020) (0)

This paper list is powered by the following services:

Other Resources About Sarah Bell

What Schools Are Affiliated With Sarah Bell?

Sarah Bell is affiliated with the following schools:

Sarah Bell's Academic­Influence.com Rankings

Sarah Bell's Degrees

Why Is Sarah Bell Influential?

Sarah Bell's Published Works

Published Works

Other Resources About Sarah Bell

What Schools Are Affiliated With Sarah Bell?

Sarah Bell's AcademicInfluence.com Rankings